Coles N Anthony's Form 4 filing
Cerevel Therapeutics Holdings, Inc. (CERE) · filed Sep 8, 2023
- Accession no.
- 0000950170-23-047297
- Filed
- Sep 8, 2023
- Trade date
- Sep 7, 2023
- Filing delay
- 1 day
- Rule 10b5-1 plan
- Not checked
This filing lists 2 non-derivative transactions and 1 derivative transaction. Open-market sales total $1.20M. It was filed 1 day after the trade.
Reporting owners
A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.
| Owner | Relationship to the company |
|---|---|
| Coles N AnthonyCIK 0001197018 | Director |
Non-derivative securities (Table I)
Acquisitions and disposals of common stock and similar shares, one row per line on the filing.
| Trade date | Security | Transaction | Shares | Price | Value | Shares after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Sep 7, 2023 | Common Stock | MOption exerciseAcquired | +50,000 | $3.50 | +$175,000 | 52,704 | Direct | |
| Sep 7, 2023 | Common Stock | SSaleDisposed | −50,000 | $24.07 | −$1,203,500 | 2,704 | Direct |
Derivative securities (Table II)
Options, warrants, restricted stock units and similar. Shares are the underlying shares; price and value are for the derivative itself, and the holding after is in derivative units.
| Trade date | Security | Transaction | Underlying shares | Unit price | Value | Held after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Sep 7, 2023 | Common Stock | MOption exerciseDisposed | −50,000 | $0.00 | $0 | 2,652,417 | Direct |
Footnotes
Livermore does not store Form 4 footnotes. For price ranges, how indirect holdings are held and trading plan details, read the original on SEC EDGAR.